$15.3 M

EVOK Mkt cap, 10-Jun-2019
Evoke Pharma Net income (FY, 2018)-7.6 M
Evoke Pharma EBIT (FY, 2018)-8 M
Evoke Pharma Cash, 31-Dec-20185.3 M

Evoke Pharma Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

R&D expense

957.0k10.0m8.2m7.0m7.1m4.1m

General and administrative expense

1.6m3.2m3.7m3.6m4.1m3.9m

Operating expense total

2.6m13.2m11.8m10.5m11.2m8.0m

EBIT

(2.6m)(13.2m)(11.8m)(10.5m)(11.2m)(8.0m)

Interest expense

159.9k107.8k268.0k6.5k

Interest income

6.5k15.2k

Net Income

(2.8m)(13.2m)(12.1m)(10.7m)(12.2m)(7.6m)

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

R&D expense

2.2m1.8m2.0m2.1m1.3m770.7k2.0m2.7m1.4m1.4m

General and administrative expense

976.4k819.7k1.1m802.7k830.1k1.2m872.0k984.0k1.0m917.3k

Operating expense total

3.2m2.7m3.2m2.9m2.2m2.0m2.9m3.7m2.4m2.3m

EBIT

(3.2m)(2.7m)(3.2m)(2.9m)(2.2m)(2.0m)(2.9m)(3.7m)(2.4m)(2.3m)

Interest expense

77.7k78.4k123.2k964.01.7k2.8k

Interest income

1.1k470.0964.01.7k2.8k1.4k2.9k

Net Income

(3.2m)(2.7m)(3.2m)(3.0m)(3.0m)(5.1m)(1.6m)(5.2m)(2.0m)(2.3m)

Evoke Pharma Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

24.2m14.2m8.7m9.0m7.7m5.3m

Accounts Receivable

Inventories

Current Assets

24.4m15.2m9.5m9.3m7.9m5.6m

Total Assets

25.0m15.3m9.5m9.3m7.9m5.7m

Accounts Payable

284.9k1.0m927.6k478.2k1.0m476.2k

Short-term debt

1.4m150.4k146.1k146.1k

Current Liabilities

2.3m1.9m1.8m1.4m2.1m1.6m

Long-term debt

1.5m4.2m4.2m4.2m

Total Debt

3.0m4.4m4.4m4.4m

Total Liabilities

3.8m6.1m5.5m5.8m1.6m

Additional Paid-in Capital

43.9m45.1m51.5m62.6m73.2m82.6m

Retained Earnings

(35.9m)(48.1m)(58.8m)(71.0m)(78.6m)

Total Equity

21.2m9.2m3.5m3.8m2.2m4.0m

Debt to Equity Ratio

0.1 x0.5 x1.3 x1.2 x

Debt to Assets Ratio

0.1 x0.3 x0.5 x0.5 x

Financial Leverage

1.2 x1.7 x2.8 x2.5 x3.7 x1.4 x

Evoke Pharma Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(2.8m)(13.2m)(12.1m)(10.7m)(12.2m)(7.6m)

Accounts Receivable

Inventories

Accounts Payable

327.9k866.6k(20.5k)(276.7k)663.2k(440.4k)

Cash From Operating Activities

(3.0m)(11.5m)(10.5m)(8.7m)(8.7m)(7.0m)

Cash From Financing Activities

27.1m1.5m5.0m9.0m7.4m4.6m

Interest Paid

128.9k58.8k230.3k169.8k

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(3.2m)(2.7m)(3.2m)(3.0m)(3.0m)(5.1m)

Accounts Payable

1.3m1.0m1.4m1.4m1.3m1.2m1.3m498.1k549.0k

Evoke Pharma Ratios

USDY, 2018

Financial Leverage

1.4 x